What is the best replacement for OxyContin (oxycodone)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: June 25, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

The best replacement for OxyContin (oxycodone) is often considered to be extended-release morphine (such as MS Contin), typically starting at 15-30mg every 12 hours and titrated based on response, as it provides effective pain control while minimizing risks of side effects, dependency, and other complications. For moderate to severe pain requiring long-acting opioid therapy, this alternative is frequently recommended 1. Non-opioid alternatives that may be appropriate include acetaminophen (up to 3000mg daily divided into doses), NSAIDs like ibuprofen (400-800mg three times daily) or naproxen (500mg twice daily), or adjuvant medications such as gabapentin (starting at 300mg daily and gradually increasing) for neuropathic pain 1.

Some key points to consider when replacing OxyContin include:

  • The individual's specific pain condition, medical history, and treatment goals
  • The potential benefits and risks of different medications, including side effects, dependency, and other complications
  • The importance of a multimodal approach combining medications with physical therapy, cognitive behavioral therapy, and other non-pharmacological interventions for chronic pain management
  • The need for careful consideration of tapering schedules when transitioning from OxyContin to prevent withdrawal symptoms

It's also important to note that combination therapies, such as the combination of gabapentin and extended-release morphine, may be effective in achieving better pain relief with lower dosages of both medications 1. However, the choice of replacement medication should be made on a case-by-case basis, taking into account the individual's unique needs and circumstances. Any medication change should be done under medical supervision to ensure the best possible outcome.

From the FDA Drug Label

The conversion factors in this table are only for the conversion from one of the listed oral opioid analgesics to OXYCONTIN The table cannot be used to convert from OXYCONTIN to another opioid. Consider the following when using the information in Table 1. This is not a table of equianalgesic doses.

The best replacement for OxyContin (oxycodone) is not explicitly stated in the provided drug labels. However, the labels provide guidance on converting from other opioids to OXYCONTIN.

  • Key points:
    • The conversion factors are only for converting from other oral opioid analgesics to OXYCONTIN.
    • It is safer to underestimate a patient's 24-hour oral oxycodone requirements and provide rescue medication than to overestimate and manage an adverse reaction due to an overdose.
    • Close observation and frequent titration are warranted until pain management is stable on the new opioid.
    • Monitor patients for signs and symptoms of opioid withdrawal and for signs of oversedation/toxicity after converting patients to OXYCONTIN.
    • The formula for conversion from prior opioids to the daily dose of OXYCONTIN is mg per day of prior opioid x factor = mg per day of OXYCONTIN.
    • Divide the calculated total daily dose by 2 to get the every-12-hour OXYCONTIN dose.
    • If rounding is necessary, always round the dose down to the nearest OXYCONTIN tablet strength available. 2 2

From the Research

Alternatives to OxyContin (Oxycodone)

When considering alternatives to OxyContin (oxycodone), several factors must be taken into account, including the type and severity of pain, patient health status, and potential side effects. The following are some alternatives that have been studied:

  • Morphine: Morphine is another opioid that has been widely used for pain management, including cancer and non-cancer pain 3, 4. However, its use may be limited by its side effects and potential for abuse.
  • Fentanyl: Fentanyl is a potent opioid that is available in transdermal formulation, which may be beneficial for patients with chronic pain 3. However, its use requires careful dosing and monitoring due to its potential for respiratory depression.
  • Buprenorphine: Buprenorphine is a partial opioid agonist that has been shown to be effective in managing chronic pain, including neuropathic pain 3, 4. It has a ceiling effect for respiratory depression, which may make it a safer alternative to other opioids.
  • Gabapentin: Gabapentin is an anticonvulsant that has been shown to be effective in managing neuropathic pain, including painful diabetic neuropathy 5. It may be used alone or in combination with opioids, such as oxycodone.
  • Multi-modal analgesic strategies: Multi-modal analgesic strategies, which involve the use of multiple medications and therapies, may be effective in managing acute and chronic pain while minimizing opioid exposure 6. These strategies may include the use of non-opioid medications, such as acetaminophen, naproxen, and gabapentin, as well as alternative therapies, such as lidocaine patches.

Key Considerations

When selecting an alternative to OxyContin (oxycodone), the following key considerations should be taken into account:

  • Efficacy: The alternative medication or strategy should be effective in managing the patient's pain.
  • Safety: The alternative medication or strategy should have a favorable safety profile, with minimal potential for side effects and abuse.
  • Tolerability: The alternative medication or strategy should be well-tolerated by the patient, with minimal potential for adverse events.
  • Individualization: The alternative medication or strategy should be individualized to the patient's specific needs and health status.

Potential Benefits and Risks

The potential benefits and risks of alternative medications and strategies should be carefully considered, including:

  • Synergistic analgesia: The use of multiple medications or therapies may result in synergistic analgesia, which can enhance pain relief while minimizing side effects 7.
  • Reduced opioid exposure: Alternative medications and strategies may reduce opioid exposure, which can minimize the risk of abuse and side effects 6.
  • Increased risk of adverse events: The use of multiple medications or therapies may increase the risk of adverse events, such as drug interactions and side effects 3, 4.

Related Questions

What is the equianalgesic dose of fentanyl (transdermal fentanyl) patch for 2.5mg of intravenous (IV) hydromorphone?
What is the equivalent dose of oxycodone (OxyContin) for a patient receiving 4mg of intravenous (IV) morphine (Morphine sulfate)?
Is 1mg buprenorphine (partial opioid agonist) twice daily sufficient for a 62-year-old female patient switched from 50mg daily oxycodone (full opioid agonist), and are additional support medications necessary for adequate pain control and withdrawal management?
What are the best pain control options for an 80-year-old man with peripheral vascular disease (PVD) experiencing phantom limb pain at the site of a toe amputation, unresponsive to paracetamol (acetaminophen) and exacerbated by opioid-induced confusion?
What is the comparison between 0.5 milligrams of intravenous (IV) hydromorphone and 10 milligrams of oral (PO) oxycodone?
What is the significance of an elevated right ventricular (RV) pressure of 33mmHg?
Is a creatinine level of 1.58 and eGFR (estimated Glomerular Filtration Rate) of 36, indicating impaired renal function, significant enough to warrant a reduced dose of Januvia (sitagliptin) to 25mg once daily?
What are the next steps for a patient with an elevated right ventricular systolic pressure (RVSP) of 54 mmHg on echocardiogram (ECHO)?
What is seborrheic dermatitis of the scalp?
Does a non-mobile apical thrombus require systemic anticoagulation with a Direct Oral Anticoagulant (DOAC)?
Can Enterococcus bacteria contaminate a Urinary Analysis (UA)?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.